NO20076405L - Anvendelse av 24-nor-UDCA - Google Patents

Anvendelse av 24-nor-UDCA

Info

Publication number
NO20076405L
NO20076405L NO20076405A NO20076405A NO20076405L NO 20076405 L NO20076405 L NO 20076405L NO 20076405 A NO20076405 A NO 20076405A NO 20076405 A NO20076405 A NO 20076405A NO 20076405 L NO20076405 L NO 20076405L
Authority
NO
Norway
Prior art keywords
liver disease
udca
noresodoxycholic
ectoliacic
medicament
Prior art date
Application number
NO20076405A
Other languages
English (en)
Other versions
NO340318B1 (no
Inventor
Michael Trauner
Alan Hofmann
Peter Fickert
Original Assignee
Univ Graz Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Graz Med filed Critical Univ Graz Med
Publication of NO20076405L publication Critical patent/NO20076405L/no
Publication of NO340318B1 publication Critical patent/NO340318B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Den foreliggende oppfinnelsen angår bruken av norursodeoksykolsyre for fremstillingen av et medikament for behandling og/eller forebygging av leversykdommer, fortrinnsvis Ictoliiske leversykdommer.
NO20076405A 2005-05-12 2007-12-12 Anvendelse av 24-nor-UDCA NO340318B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/052178 WO2006119803A1 (en) 2005-05-12 2005-05-12 USE OF 24-nor-UDCA

Publications (2)

Publication Number Publication Date
NO20076405L true NO20076405L (no) 2008-02-11
NO340318B1 NO340318B1 (no) 2017-03-27

Family

ID=35457032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076405A NO340318B1 (no) 2005-05-12 2007-12-12 Anvendelse av 24-nor-UDCA

Country Status (17)

Country Link
US (1) US8951995B2 (no)
EP (4) EP2392335B1 (no)
AU (1) AU2005331734B2 (no)
CY (4) CY1116831T1 (no)
DK (4) DK2392336T3 (no)
EA (1) EA014077B1 (no)
ES (4) ES2590333T3 (no)
HR (3) HRP20150949T1 (no)
HU (4) HUE028336T2 (no)
LT (1) LT2392336T (no)
ME (3) ME02544B (no)
NO (1) NO340318B1 (no)
PL (4) PL1890705T3 (no)
PT (3) PT2392337E (no)
RS (3) RS55180B1 (no)
SI (4) SI2392336T1 (no)
WO (1) WO2006119803A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
ES2709489T3 (es) * 2007-07-25 2019-04-16 Univ Graz Medizinische Uso de ácidos nor-biliares en el tratamiento de arteriosclerosis
EP2468762A1 (en) * 2010-11-30 2012-06-27 Dr. Falk Pharma Gmbh Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
EP3461485A1 (en) 2017-09-28 2019-04-03 Dr. Falk Pharma Gmbh Use of nor-ursodeoxycholic acid for reducing liver fat
GB201911821D0 (en) 2019-08-16 2019-10-02 Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy And Undivid Compounds for use in the treatment of liver disease
US11372809B2 (en) * 2019-09-27 2022-06-28 Oracle International Corporation System and method for providing correlated content organization in an enterprise content management system based on a training set
WO2021130232A1 (en) 2019-12-23 2021-07-01 Medizinische Universität Wien Bile acid derivatives in the medical intervention of anxieties and/or stress symptoms
WO2021152430A1 (en) * 2020-01-28 2021-08-05 Shilpa Medicare Limited Method for administration of ursodeoxycholic acid
CN114195850B (zh) * 2020-09-18 2024-08-16 成都贝诺科成生物科技有限公司 一种用于防治肝病的化合物及其制药用途
CA3259229A1 (en) * 2022-07-25 2024-02-01 Shilpa Medicare Limited NOR-UDCA PHARMACEUTICAL COMPOSITIONS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892868A (en) 1984-08-17 1990-01-09 Gipharmex, S.P.A. Derivatives of biliary acids, process for the production thereof and corresponding pharmaceutical compositions
IT1229569B (it) 1989-04-17 1991-09-04 Giuliani Spa Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT1255449B (it) 1992-06-30 1995-10-31 Fabio Berlati Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
TW289020B (no) 1993-05-08 1996-10-21 Hoechst Sktiengesellschaft
ITMI20012572A1 (it) 2001-12-06 2003-06-06 Istituto Biochimico Italiano Microgranuli di acido ursodesossicolico

Also Published As

Publication number Publication date
ME02544B (me) 2017-02-20
EP1890705A1 (en) 2008-02-27
PL1890705T3 (pl) 2016-05-31
ME02737B (me) 2015-12-31
EP2392337B1 (en) 2015-07-29
EP2392337A3 (en) 2012-01-04
HRP20151091T1 (hr) 2015-11-06
HUE025409T2 (en) 2016-02-29
RS55180B1 (sr) 2017-01-31
DK2392337T3 (en) 2015-09-28
EP2392336A3 (en) 2011-12-28
CY1117174T1 (el) 2017-04-05
AU2005331734A1 (en) 2006-11-16
HRP20150949T1 (hr) 2015-12-04
EP2392335B1 (en) 2015-06-24
HUE030010T2 (en) 2017-04-28
EP2392337A2 (en) 2011-12-07
DK2392336T3 (en) 2016-09-05
PL2392335T3 (pl) 2015-10-30
PT2392335E (pt) 2015-10-06
PT2392336T (pt) 2016-10-04
SI2392336T1 (sl) 2016-10-28
PL2392336T3 (pl) 2016-12-30
EP2392336B1 (en) 2016-06-22
RS54140B1 (sr) 2015-12-31
SI1890705T1 (sl) 2016-02-29
WO2006119803A1 (en) 2006-11-16
HRP20161197T1 (hr) 2016-11-04
SI2392335T1 (sl) 2015-10-30
AU2005331734B2 (en) 2012-04-19
EA014077B1 (ru) 2010-08-30
CY1117959T1 (el) 2017-05-17
ES2561614T3 (es) 2016-02-29
NO340318B1 (no) 2017-03-27
DK2392335T3 (en) 2015-06-29
ES2550204T3 (es) 2015-11-05
CY1116831T1 (el) 2017-03-15
CY1116840T1 (el) 2017-03-15
EP2392336A2 (en) 2011-12-07
HK1161122A1 (en) 2012-08-24
HUE025184T2 (en) 2016-01-28
EP2392335A2 (en) 2011-12-07
EP2392335A3 (en) 2011-12-28
ES2547127T3 (es) 2015-10-01
LT2392336T (lt) 2016-10-10
SI2392337T1 (sl) 2015-10-30
PL2392337T3 (pl) 2015-12-31
EA200702336A1 (ru) 2008-04-28
HUE028336T2 (en) 2016-12-28
US8951995B2 (en) 2015-02-10
US20090163459A1 (en) 2009-06-25
RS54185B1 (sr) 2015-12-31
ES2590333T3 (es) 2016-11-21
EP1890705B1 (en) 2015-11-11
PT2392337E (pt) 2015-11-02
ME02256B (me) 2015-12-31
DK1890705T3 (en) 2016-02-01

Similar Documents

Publication Publication Date Title
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA200802213A1 (ru) Способы лечения заболеваний крови
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
EA201690265A2 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
UA102065C2 (xx) Заміщені 4-арил-1,4-дигідро-1,6-нафтиридинаміди і їх застосування$замещенные 4-арил-1,4-дигидро-1,6-нафтиридинамиды и их применение
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
EP1623046A4 (en) Compositions and methods for treating severe acute respiratory syndrome (SARS)
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
EP1851237A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING BONE DISORDERS
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
CY1118179T1 (el) Φαρμακευτικη συνθεση
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
DK1594833T3 (da) 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
CY1116840T1 (el) Χρηση 24-norudca
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
EA200801481A1 (ru) 5-(арилсульфонил)пиразолопиперидины
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees